Business
Pfizer releases antiviral pill Paxlovid, a promising new weapon in the fight against the COVID-19 pandemic – 7NEWS
Trials for the experimental antiviral pill Paxlovid were stopped early due to its high success rate.
Pfizer Incs experimental antiviral pill to treat COVID-19 cuts by 89 per cent the chances of hospitalisation or death for adults at risk of developing severe disease, the company says, offering what could be a promising new weapon in the fight against the…
Continue Reading
